Literature DB >> 9001653

Essential fatty acid deficiency and predisposition to lung disease in cystic fibrosis.

J D Lloyd-Still1, D M Bibus, C A Powers, S B Johnson, R T Holman.   

Abstract

UNLABELLED: Essential fatty acid (EFA) deficiency is a predisposing factor for pulmonary infection with Staphylococcus aureus and Pseudomonas aeruginosa, the two major pathogenic microorganisms in cystic fibrosis (CF).
OBJECTIVE: The goal of this study was to investigate the essential fatty acid status of CF patients from infancy to 20 years old.
MATERIALS AND METHODS: Plasma fatty acid profiles for phospholipid (PL) were determined for cord (n = 6), 4 months (n = 40), 16 months (n = 25), 3 y (n = 8), 5-10 y (n = 10), and 10-20 y (n = 10) aged CF patients and compared to their respective control; cord (n = 22), 1-36 months (n = 38) and adult (n = 100). Significance was established by Student's t-test (p < 0.05).
RESULTS: The plasma PL fatty acid profile for all CF patients, except cord, revealed consistent deficiency in omega 3 and omega 6 EFAs. These deficiencies were most marked at infancy and more pronounced for patients with meconium ileus. CONCLUSIONS AND RELEVANCE: EFA deficiency may contribute to the predisposition of CF infants to develop respiratory disease and to the excess cytotoxic activity found in bronchoalveolar lavage fluid at 2 months of age in the majority of screened infants.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9001653     DOI: 10.1111/j.1651-2227.1996.tb13947.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  8 in total

1.  Omega-3 fatty acid supplementation for cystic fibrosis.

Authors:  Helen Watson; Caroline Stackhouse
Journal:  Cochrane Database Syst Rev       Date:  2020-04-10

2.  Relation between dietary fat intake type and serum fatty acid status in children with cystic fibrosis.

Authors:  Asim Maqbool; Joan I Schall; Paul R Gallagher; Babette S Zemel; Birgitta Strandvik; Virginia A Stallings
Journal:  J Pediatr Gastroenterol Nutr       Date:  2012-11       Impact factor: 2.839

Review 3.  Omega-3 fatty acids for cystic fibrosis.

Authors:  Colleen Oliver; Helen Watson
Journal:  Cochrane Database Syst Rev       Date:  2016-01-05

4.  Effect of a dietary intervention on growth and energy expenditure in children with cystic fibrosis.

Authors:  Veronique Groleau; Joan I Schall; Kelly A Dougherty; Norma E Latham; Asim Maqbool; Maria R Mascarenhas; Virginia A Stallings
Journal:  J Cyst Fibros       Date:  2014-02-08       Impact factor: 5.482

5.  Mechanisms of lipid malabsorption in Cystic Fibrosis: the impact of essential fatty acids deficiency.

Authors:  N Peretti; V Marcil; E Drouin; E Levy
Journal:  Nutr Metab (Lond)       Date:  2005-05-03       Impact factor: 4.169

6.  Determinants of Serum Glycerophospholipid Fatty Acids in Cystic Fibrosis.

Authors:  Sławomira Drzymała-Czyż; Patrycja Krzyżanowska; Berthold Koletzko; Jan Nowak; Anna Miśkiewicz-Chotnicka; Jerzy A Moczko; Aleksandra Lisowska; Jarosław Walkowiak
Journal:  Int J Mol Sci       Date:  2017-01-18       Impact factor: 5.923

Review 7.  Nutrition in Cystic Fibrosis-Some Notes on the Fat Recommendations.

Authors:  Birgitta Strandvik
Journal:  Nutrients       Date:  2022-02-18       Impact factor: 5.717

Review 8.  Dietary fatty acids and immune response to food-borne bacterial infections.

Authors:  Lisa M Harrison; Kannan V Balan; Uma S Babu
Journal:  Nutrients       Date:  2013-05-22       Impact factor: 5.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.